Physician profile
Jared Patrick Steinberger
NPI 1497241350
$8,516.27
in general payments reported to CMS, 2019-2025
23 companies · $2,650 in 2025
The $2,650 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.74 · 2021: $716 · 2022: $1,292 · 2023: $1,604 · 2024: $2,238 · 2025: $2,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,943 · Travel and Lodging: $2,386 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,943.31 |
| Travel and Lodging | $2,385.59 |
| Education | $162.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,106.96 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $1,775.19 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Hawkone |
| Abbott Laboratories | $1,091.49 | 2023-2025 | Amplatzer Amulet, Dragonfly Opstar, Perclose Proglide |
| Amgen INC. | $723.44 | 2021-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $642.70 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $437.99 | 2021-2024 | Rotablator Rotational Atherectomy System Console Kit, Watchman Access System |
| Penumbra, INC. | $295.49 | 2021-2024 | Penumbra System |
| Janssen Pharmaceuticals, INC | $282.39 | 2021-2023 | Xarelto |
| Abiomed | $150.88 | 2022-2023 | Impella |
| Angiodynamics, INC. | $144.50 | 2024 | Alphavac |
| Philips North America LLC | $143.40 | 2023-2024 | (Ao0) Igt Devices Intracardiac |
| E.R. Squibb & Sons, L.L.C. | $123.97 | 2021 | |
| Impulse Dynamics (USA) INC. | $122.20 | 2024 | Optimizer |
| Inari Medical, INC. | $103.28 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genzyme Corporation | $83.33 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $76.59 | 2022 | |
| Merck Sharp & Dohme LLC | $70.65 | 2022 | |
| Chiesi USA, INC. | $39.05 | 2023-2024 | Cleviprex, Kengreal |
| Astrazeneca Pharmaceuticals Lp | $28.75 | 2024 | Wainua |
| Janssen Scientific Affairs, LLC | $20.10 | 2023 | Xarelto |
| Pfizer INC. | $19.93 | 2025 | |
| Terumo Medical Corporation | $17.06 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $16.93 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Steinberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.